Neuromyelitis optica is an autoimmune disease involving the inflammation and demyelination of the optic nerve (optic neuritis) and spinal cord (myelitis). Attacks of the disease are often severe and difficult to treat, resulting in lingering deficits for patients. Recently, a group of researchers on behalf of the Neuromyelitis Optica Study Group conducted a retrospective review of patient records from the NEMOS registry (1), (2) to determine the nature and severity of attacks, the rates of remission after attacks, and the efficacy of the most common therapies. The following graphs represent their results.
References
- I Kleiter et al., “Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses”, Ann Neurol, [Epub ahead of print] (2015). PMID: 26537743. Neuromyelitis optica Studiengruppe, “NEMOS” (2015). Available at: http://www.nemos-net. de. Accessed December 17, 2015.
